RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Canntab Therapeutics Stock

Canntab Therapeutics Debt 2024

Canntab Therapeutics Debt

1.15 CAD

Ticker

PILL.CN

ISIN

CA1377991023

WKN

A2JKBY

In 2024, Canntab Therapeutics's total debt was 1.15 CAD, a 1,431.25% change from the 0.08 CAD total debt recorded in the previous year.

Canntab Therapeutics Aktienanalyse

What does Canntab Therapeutics do?

Canntab Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Canntab Therapeutics's Debt Structure

Canntab Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Canntab Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Canntab Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Canntab Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Canntab Therapeutics stock

What is the debt of Canntab Therapeutics this year?

Canntab Therapeutics has a debt level of 1.15 CAD this year.

What was the debt of Canntab Therapeutics compared to the previous year?

The debt of Canntab Therapeutics has increased by 1,431.25% compared to the previous year increased.

What are the consequences of high debt for investors in Canntab Therapeutics?

High debt can pose a risk for investors of Canntab Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Canntab Therapeutics?

Low debt means that Canntab Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Canntab Therapeutics affect the company?

An increase in debt of Canntab Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Canntab Therapeutics affect the company?

A reduction in debt of Canntab Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Canntab Therapeutics?

Some factors that can influence the debt of Canntab Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Canntab Therapeutics so important for investors?

The debts of Canntab Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Canntab Therapeutics take to change the debt?

To change the debt, Canntab Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Canntab Therapeutics pay?

Over the past 12 months, Canntab Therapeutics paid a dividend of 2.9 CAD . This corresponds to a dividend yield of about 58,000 %. For the coming 12 months, Canntab Therapeutics is expected to pay a dividend of 0 CAD.

What is the dividend yield of Canntab Therapeutics?

The current dividend yield of Canntab Therapeutics is 58,000 %.

When does Canntab Therapeutics pay dividends?

Canntab Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Canntab Therapeutics?

Canntab Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Canntab Therapeutics?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Canntab Therapeutics located?

Canntab Therapeutics is assigned to the '-' sector.

Wann musste ich die Aktien von Canntab Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Canntab Therapeutics from 4/30/2016 amounting to 0.015 CAD, you needed to have the stock in your portfolio before the ex-date on 3/8/2016.

When did Canntab Therapeutics pay the last dividend?

The last dividend was paid out on 4/30/2016.

What was the dividend of Canntab Therapeutics in the year 2023?

In the year 2023, Canntab Therapeutics distributed 0 CAD as dividends.

In which currency does Canntab Therapeutics pay out the dividend?

The dividends of Canntab Therapeutics are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Canntab Therapeutics

Our stock analysis for Canntab Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Canntab Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.